Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency
Ying Li, Dandan Yang, Yian Wang, Zhan Li, Chunyan Zhu Drug Delivery Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, People’s Republic of China Background: To establish the combination of doxorub...
Guardado en:
Autores principales: | Li Y, Yang D, Wang Y, Li Z, Zhu C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea48108eafa8459e8410c0fda7ab82fb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanism of hepatic targeting via oral administration of DSPE–PEG–cholic acid-modified nanoliposomes
por: Li Y, et al.
Publicado: (2017) -
Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy
por: Qu D, et al.
Publicado: (2017) -
Intelligently responsive amphiphilic small molecule loaded with doxorubicin to form highly effective anti-hepatocarcinoma nanomicelles
por: Chunxiao Gao, et al.
Publicado: (2021) -
Liver-Targeting and pH-Sensitive Sulfated Hyaluronic Acid Mixed Micelles for Hepatoma Therapy
por: Li Z, et al.
Publicado: (2019) -
Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
por: Lian B, et al.
Publicado: (2021)